Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage. SeekIn is a startup focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030. Our proprietary ctDNA mutation detection technology has demonstrated its promise to identify asymptomatic cancer patients from general population.